VeriMomVeriMom

¿Es copper heptapeptide-14 pantothenate seguro durante el embarazo?

No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for this specific ingredient name; no peer‑reviewed reproductive or developmental toxicity data located in the cited sources. Topical copper‑peptide complexes and peptide salts generally have low dermal systemic bioavailability, so exposure from normal cosmetic use is expected to be negligible. Sources checked: ECHA Annex VI (harmonised CLP) = no entry; CIR/SCCS = no safety assessment for this exact ingredient; PubMed = no reproductive/developmental studies found.

Ingredientes
copper heptapeptide-14 pantothenate
SIN RIESGOS CONOCIDOS
100
/100
0

Pregnancy-safe products containing copper heptapeptide-14 pantothenate

Related ingredients

Frequently asked questions

¿Es copper heptapeptide-14 pantothenate seguro durante el embarazo?
No harmonised CLP reproductive classification or SCCS/CIR safety assessment was identified for this specific ingredient name; no peer‑reviewed reproductive or developmental toxicity data located in the cited sources. Topical copper‑peptide complexes and peptide salts generally have low dermal systemic bioavailability, so exposure from normal cosmetic use is expected to be negligible. Sources checked: ECHA Annex VI (harmonised CLP) = no entry; CIR/SCCS = no safety assessment for this exact ingredient; PubMed = no reproductive/developmental studies found.
¿Es copper heptapeptide-14 pantothenate seguro durante la lactancia?
No evidence of lactation/breastmilk transfer or reproductive hazard for this specific ingredient in the available regulatory and literature sources. Given the lack of systemic reproductive/toxicological data and expected low dermal absorption of peptide complexes, systemic exposure in lactating persons from cosmetic topical use is expected to be negligible. Sources checked: ECHA Annex VI, CIR, PubMed, CosIng, PubChem.
¿Es copper heptapeptide-14 pantothenate seguro para la piel del bebé?
No infant‑specific toxicity or dermal absorption studies were identified. By default there is no evidence of reproductive or developmental hazard, but infant skin has higher permeability; while adult topical exposure is assessed as negligible, a precautionary modest increase in exposure score (e=1) is applied for 0–3 yr skin due to the immature barrier and higher surface‑area‑to‑weight ratio. No harmonised CLP flags or specific SCCS/CIR guidance for infant use were found.
¿Cómo puntúa VeriMom a copper heptapeptide-14 pantothenate?
VeriMom puntúa copper heptapeptide-14 pantothenate en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
¿Cuáles son las alternativas seguras a copper heptapeptide-14 pantothenate en el embarazo?
Consulta nuestra lista de alternativas seguras a copper heptapeptide-14 pantothenate según función similar y clasificación sin riesgos conocidos.

Comprueba cualquier etiqueta en 2 segundos

Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.

Aviso Médico

Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.

Obtén la experiencia completa en la app VeriMom